Revenue
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
iBio, Inc. (IBIO)
Price$1.31Cached quote
Net income
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $100,000 | $400,000 | $225,000 | $0 | $1.9M | $2.4M | $0 | $37,000 | $44,000 | $394,000 | $948,000 | $1.9M | $205,000 | $1.0M | $1.3M | $520,080 |
| Gross profit | — | — | — | — | $2.2M | $909,000 | $935,000 | — | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | 115.02% | 38.34% | — | — | — | — | — | — | — | — | — | — |
| Research & development | $19.6M | $8.3M | $5.2M | $10.3M | $9.8M | $10.0M | $3.6M | $5.5M | $4.0M | $4.1M | $3.2M | $3.5M | $1.9M | $3.4M | $5.0M | $3.1M |
| Operating expenses | $35.2M | $19.0M | $16.9M | $29.3M | $31.6M | $32.0M | $14.9M | $17.8M | $14.7M | $14.7M | $10.8M | $8.5M | $4.0M | $7.7M | $10.6M | $10.2M |
| Operating income | −$35.1M | −$18.6M | −$16.6M | −$29.3M | −$29.7M | −$31.1M | −$14.0M | −$15.8M | −$14.2M | −$14.3M | −$9.9M | −$6.7M | −$3.8M | −$6.7M | −$9.3M | −$9.7M |
| Operating margin | −35,141.00% | −4,650.50% | −7,392.89% | — | −1,576.27% | −1,312.15% | — | −42,670.27% | −32,334.09% | −3,622.84% | −1,043.57% | −360.13% | −1,873.17% | −662.07% | −730.38% | −1,856.25% |
| EBITDA | −$34.6M | −$18.1M | −$16.0M | −$28.5M | −$27.0M | −$30.3M | −$13.4M | −$15.6M | −$12.5M | −$12.6M | −$9.0M | −$6.3M | −$3.5M | −$6.3M | −$9.0M | −$9.3M |
| EBITDA margin | −34,563.00% | −4,524.50% | −7,100.44% | — | −1,434.24% | −1,279.97% | — | −42,186.49% | −28,450.00% | −3,197.46% | −944.41% | −340.52% | −1,697.07% | −628.50% | −704.56% | −1,783.80% |
| Net income | −$33.0M | −$18.4M | −$24.9M | −$65.0M | −$50.3M | −$23.2M | −$16.4M | −$17.6M | −$16.1M | −$14.5M | −$9.8M | −$6.6M | −$3.7M | −$6.2M | −$5.7M | −$12.1M |
| Net profit margin | −33,044.00% | −4,594.25% | −11,069.78% | — | −2,670.01% | −978.79% | — | −47,548.65% | −36,602.27% | −3,688.32% | −1,029.96% | −357.91% | −1,788.29% | −615.49% | −444.48% | −2,334.73% |
| Basic EPSper basic share | -$0.32 | -$1.75 | -$6.50 | -$106.19 | -$2,312.00 | -$1,200.00 | -$152,500.00 | -$235,000.00 | -$385,000.00 | -$4,100,000.00 | -$3,000,000.00 | -$2,250,000.00 | -$1,500,000.00 | -$3,250,000.00 | -$3,500,000.00 | -$9,750,000.00 |
| Diluted EPSper diluted share | -$0.32 | -$1.75 | -$6.50 | -$106.19 | -$2,312.00 | -$1,200.00 | -$152,500.00 | -$235,000.00 | -$385,000.00 | -$4,100,000.00 | -$3,000,000.00 | -$2,250,000.00 | -$1,500,000.00 | -$3,250,000.00 | -$3,500,000.00 | -$9,750,000.00 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Parada Antonio Bernardino Guimaraes | 183.82K |
Duran Felipe | 35.97K |
Brenner Martin | 30.65K |
Banjak Marc | 25K |
Arkowitz David | 18.38K |
Sender Gary | 9.19K |
Clark William D | 1.84K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 26, 2026Form 4 | Banjak MarcChief Legal Officer | BuyCommon Stock | 1.4K | $1.76 | $2.5K | 25.0K |
| Mar 26, 2026Form 4 | Banjak MarcChief Legal Officer | BuyCommon Stock | 12.5K | $1.64 | $20.5K | 23.6K |
| Mar 19, 2026Form 4 | Duran FelipeChief Financial Officer | BuyCommon Stock | 24.8K | $2.02 | $50.2K | 36.0K |
| Mar 19, 2026Form 4 | Brenner MartinSee Remarks | BuyCommon Stock | 12.3K | $2.02 | $24.9K | 30.7K |
| Jan 10, 2025Form 4 | Duran FelipeChief Financial Officer | BuyCommon Stock | 9.2K | $2.72 | $25.0K | 11.1K |